  {"id":92938,"date":"2026-02-04T13:03:30","date_gmt":"2026-02-04T12:03:30","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?post_type=resources&#038;p=92938"},"modified":"2026-07-16T12:40:49","modified_gmt":"2026-07-16T10:40:49","slug":"13-of-the-top-20-biopharmas-standardize-globally-on-veeva-link-key-people","status":"publish","type":"resources","link":"https:\/\/www.veeva.com\/eu\/resources\/13-of-the-top-20-biopharmas-standardize-globally-on-veeva-link-key-people\/","title":{"rendered":"13 of the Top 20 Biopharmas Standardize Globally<br> on ³Ô¹Ï±¬ÁÏ Link Key People"},"content":{"rendered":"<p align=\"center\"><i>Emerging biotechs and top biopharmas trust Link to power customer engagement and provide structured datasets to fuel AI initiatives<\/i><\/p>\n<p>\n<strong>BARCELONA, Spain \u2014 4 Feb 2026 \u2014<\/strong> <a href=\"\/eu\/\">³Ô¹Ï±¬ÁÏ Systems<\/a> (NYSE: VEEV) today announced that 13 of the top 20 biopharmas have standardized on <a href=\"\/eu\/products\/veeva-link\/\">³Ô¹Ï±¬ÁÏ Link Key People<\/a> to enhance customer engagement and provide data for AI globally. Biopharmas of all sizes use Link Key People, with 38 new customers added and three of the top 20 biopharmas making it their global standard within the last year.\n<\/p>\n<p>\n\u201cAccess to ³Ô¹Ï±¬ÁÏ Link Key People further strengthens data-driven decision-making, enhances laser-sharp targeting, and fosters more engaging HCP interactions \u2014 altogether benefiting patient healthcare. As ingested, Link Key People data has become an organic part of Bayer\u2019s Data DNA, it enriches the outputs of our agentic, AI-driven platforms, delivering more relevant and actionable business insights for the long-term benefit of patients,\u201d said Dr. Daniel Jardanhazi-Kurutz, deputy director for customer engagement at Bayer AG.\n<\/p>\n<p>\nLink Key People delivers value to medical and commercial teams by providing trusted insights, while analytics teams can use Link data to feed their AI models. Recent innovations, such as AI-powered summaries, personalized notifications, and new digital data sources, further improve customer interactions and help to uncover new engagement opportunities. Additionally, the <a href=\"\/eu\/products\/link-direct-data-api\/\">Link Direct Data API<\/a> gives data teams access to ³Ô¹Ï±¬ÁÏ\u2019s new class of API that provides high-speed access to data.\n<\/p>\n<p>\n\u201cTrusted customer insights are the foundation for AI advancement and help achieve launch performance. With more top biopharmas and emerging biotechs using Link Key People, we will continue to learn and advance engagement across the industry with deep KOL data for strategic and impactful relationships,\u201d said David Medina Tato, vice president of strategy for Link Key People at ³Ô¹Ï±¬ÁÏ.\n<\/p>\n<p>\n<a href=\"\/eu\/products\/veeva-link\/\">Link Key People<\/a> is part of <a href=\"\/eu\/products\/data-cloud\/\">³Ô¹Ï±¬ÁÏ Data Cloud<\/a>, which includes <a href=\"\/eu\/products\/opendata\/\">³Ô¹Ï±¬ÁÏ OpenData<\/a>, <a href=\"\/eu\/products\/hcpaccess\/\">³Ô¹Ï±¬ÁÏ HCP 360<\/a>, and <a href=\"\/products\/veeva-compass\/\" target=\"_blank\" rel=\"noopener noreferrer\">³Ô¹Ï±¬ÁÏ Compass<\/a>, and Link Key People uses ³Ô¹Ï±¬ÁÏ\u2019s <a href=\"\/eu\/cda\/\">Common Data Architecture<\/a> (CDA) to connect data and software.\n<\/p>\n<p><strong>About ³Ô¹Ï±¬ÁÏ Systems<\/strong> <br \/>\n³Ô¹Ï±¬ÁÏ delivers the industry cloud for life sciences with software, data, and business consulting. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,500 customers, ranging from the world\u2019s largest biopharmaceutical companies to emerging biotechs. As a <a href=\"\/pbc\/\" target=\"_blank\" rel=\"noreferrer noopener\">Public Benefit Corporation<\/a>, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit <a href=\"\/eu\/\">veeva.com\/eu<\/a>.\n<\/p>\n<p><strong>³Ô¹Ï±¬ÁÏ Forward-Looking Statements<\/strong> <br \/>\nThis release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended October 31, 2025, which you can find <a href=\"https:\/\/www.sec.gov\/ixviewer-plus\/ix.xhtml?doc=\/Archives\/edgar\/data\/0001393052\/000139305225000078\/veev-20251031.htm#i7e129a0ad48d459ea13c21cd7e2de073_124\" target=\"_blank\" rel=\"noreferrer noopener\">here<\/a> (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at <a href=\"https:\/\/www.sec.gov\/\" target=\"_blank\" rel=\"noreferrer noopener\">sec.gov<\/a>.\n<\/p>\n<p><center>###<\/center><\/p>\n<p>\n<strong>Contact:<\/strong><\/p>\n<p>\nMeera Lakhani-Patel <br \/>\n³Ô¹Ï±¬ÁÏ Systems <br \/>\n+44-790-430-0698 <br \/>\n<a href=\"mailto:meera.lakhani-patel@veeva.com\">meera.lakhani-patel@veeva.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Emerging biotechs and top biopharmas trust Link to power customer engagement and provide structured datasets to fuel AI initiatives.<\/p>\n","protected":false},"featured_media":93706,"parent":0,"template":"","class_list":["post-92938","resources","type-resources","status-publish","has-post-thumbnail","hentry","resource-html-content-yes","resource-area-20-data","resource-area-20-medical","resource-product-20-real-time-customer-intelligence-link","resource-type-news-press-release","resource-type-press-release"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/92938"}],"collection":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/types\/resources"}],"version-history":[{"count":2,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/92938\/revisions"}],"predecessor-version":[{"id":93796,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/92938\/revisions\/93796"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media\/93706"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media?parent=92938"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}